Semin Thromb Hemost 2019; 45(01): 001-004
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Welcome to Seminars in Thrombosis and Hemostasis 2019–New (2017) Impact Factor and Most Highly Cited Papers
Emmanuel J. Favaloro
1
Department of Haematology, Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, New South Wales, Australia
› Author Affiliations
References
1
Favaloro EJ.
The Journal Impact Factor: don't expect its demise any time soon. Clin Chem Lab Med 2009; 47 (11) 1319-1324
2
Favaloro EJ.
Measuring the quality of journals and journal articles: the impact factor tells but a portion of the story. Semin Thromb Hemost 2008; 34 (01) 7-25
3
Favaloro EJ,
Lippi G.
Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors. Semin Thromb Hemost 2015; 41 (02) 208-227
4
Mallett SV.
Clinical utility of viscoelastic tests of coagulation (TEG/ROTEM) in patients with liver disease and during liver transplantation. Semin Thromb Hemost 2015; 41 (05) 527-537
5
Gremmel T,
Frelinger III AL,
Michelson AD.
Platelet physiology. Semin Thromb Hemost 2016; 42 (03) 191-204
6
Levi M,
Poll Tv.
Coagulation in patients with severe sepsis. Semin Thromb Hemost 2015; 41 (01) 9-15
7
Prandoni P,
Bernardi E,
Valle FD.
, et al. Extensive computed tomography versus limited screening for detection of occult cancer in unprovoked venous thromboembolism: a multicenter, controlled, randomized clinical trial. Semin Thromb Hemost 2016; 42 (08) 884-890
8
Gando S,
Hayakawa M.
Pathophysiology of trauma-induced coagulopathy and management of critical bleeding requiring massive transfusion. Semin Thromb Hemost 2016; 42 (02) 155-165
9
McEwen BJ.
The influence of herbal medicine on platelet function and coagulation: a narrative review. Semin Thromb Hemost 2015; 41 (03) 300-314
10
Prandoni P,
Lensing AW,
Prins MH.
, et al. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost 2015; 41 (02) 133-140
11
Ranucci M.
Hemostatic and thrombotic issues in cardiac surgery. Semin Thromb Hemost 2015; 41 (01) 84-90
12
Johansen ME,
Johansson PI,
Ostrowski SR.
, et al. Profound endothelial damage predicts impending organ failure and death in sepsis. Semin Thromb Hemost 2015; 41 (01) 16-25
13
Valla D.
Splanchnic vein thrombosis. Semin Thromb Hemost 2015; 41 (05) 494-502
14
Dorgalaleh A,
Naderi M,
Hosseini MS.
, et al. Factor XIII deficiency in Iran: a comprehensive review of the literature. Semin Thromb Hemost 2015; 41 (03) 323-329
15
Hayakawa M,
Gando S,
Ono Y,
Wada T,
Yanagida Y,
Sawamura A.
Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. Semin Thromb Hemost 2015; 41 (01) 35-42
16
Schroeder V,
Kohler HP.
Factor XIII: structure and function. Semin Thromb Hemost 2016; 42 (04) 422-428
17
Montoro-García S,
Schindewolf M,
Stanford S,
Larsen OH,
Thiele T.
The role of platelets in venous thromboembolism. Semin Thromb Hemost 2016; 42 (03) 242-251
18
Curnow J,
Pasalic L,
Favaloro EJ.
Treatment of von Willebrand disease. Semin Thromb Hemost 2016; 42 (02) 133-146
19
van Es N,
Bleker S,
Sturk A,
Nieuwland R.
Clinical significance of tissue factor-exposing microparticles in arterial and venous thrombosis. Semin Thromb Hemost 2015; 41 (07) 718-727
20
de Groot PG,
Urbanus RT.
Antiphospholipid syndrome--not a noninflammatory disease. Semin Thromb Hemost 2015; 41 (06) 607-614
21
Suades R,
Padró T,
Badimon L.
The role of blood-borne microparticles in inflammation and hemostasis. Semin Thromb Hemost 2015; 41 (06) 590-606
22
Semeraro N,
Ammollo CT,
Semeraro F,
Colucci M.
Coagulopathy of acute sepsis. Semin Thromb Hemost 2015; 41 (06) 650-658
23
Leebeek FW,
Rijken DC.
The fibrinolytic status in liver diseases. Semin Thromb Hemost 2015; 41 (05) 474-480
24
Cuker A,
Prak ET,
Cines DB.
Can immune thrombocytopenia be cured with medical therapy?. Semin Thromb Hemost 2015; 41 (04) 395-404
25
Warkentin TE.
Heparin-induced thrombocytopenia in critically ill patients. Semin Thromb Hemost 2015; 41 (01) 49-60
26
Favaloro EJ.
2017 Eberhard F. Mammen Award Announcements: Part I-Most popular articles. Semin Thromb Hemost 2017; 43 (04) 357-363
27
Favaloro EJ.
2017 Eberhard F. Mammen Award Announcements: Part II-Young investigator awards. Semin Thromb Hemost 2018; 44 (02) 81-88
